4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+93.2%
5Y CAGR+68.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+93.2%/yr
vs +7.6%/yr prior
5Y CAGR
+68.9%/yr
Recent acceleration
Acceleration
+85.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
13.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $237.13M | +26.2% |
| 2024 | $187.88M | +414.8% |
| 2023 | $36.49M | +10.9% |
| 2022 | $32.91M | +17.5% |
| 2021 | $28.01M | +62.5% |
| 2020 | $17.24M | -9.4% |
| 2019 | $19.03M | -22.4% |
| 2018 | $24.53M | +43.8% |
| 2017 | $17.06M | - |